
- August 2012 Pain Awareness
- Volume 78
- Issue 8
Diabetes Drug Shown to Prompt New Cell Growth
The widely used diabetes drug metformin appears to encourage the growth of new brain cells, according to the results of a study published on July 6, 2012, in Cell Stem Cell. New neural cells would have the potential to help repair the effects of many neurodegenerative disorders and brain injuries.
Based on their discovery of a pathway known as PKC-CBP that signals embryonic neural stem cells to make neurons, coupled with other research that found that this pathway was activated by metformin in liver cells, the researchers theorized that metformin would activate the same pathway in neural stem cells.
The researchers found development of new neurons in the brains of mice that were taking metformin. These mice also demonstrated enhanced ability to learn and remember the route through water mazes. Finally, the researchers found that metformin promoted differentiation and genesis of human and mouse neural stem cells in culture.
“As a next step, we would be interested to see if individuals with acquired brain injury might benefit from taking metformin,” said lead researcher Freda Miller, PhD, professor in the department of molecular genetics at the University of Toronto, in a press release.
To read more articles in this watch, click:
Articles in this issue
about 13 years ago
Legal Opioids: An Octopus of a Problemabout 13 years ago
Rx Product Newsabout 13 years ago
Case Studiesabout 13 years ago
Effect of Telephonic Patient Support on Opioid Dependenceabout 13 years ago
Smoking and Ovarian Cancer Riskabout 13 years ago
Anxiety Disorders: Underdiagnosed and Undertreatedabout 13 years ago
Medication Adherence: Taking ResponsibilityNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.













































































































































































































